Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiopulmonary Resuscitation | 13 | 2024 | 190 | 2.650 |
Why?
|
| Heart Arrest | 12 | 2019 | 265 | 1.640 |
Why?
|
| Hypothermia, Induced | 7 | 2019 | 74 | 1.180 |
Why?
|
| Respiratory Rate | 1 | 2022 | 20 | 0.860 |
Why?
|
| Chest Pain | 1 | 2022 | 42 | 0.850 |
Why?
|
| Electrocardiography | 1 | 2022 | 478 | 0.730 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2019 | 332 | 0.720 |
Why?
|
| Emergency Service, Hospital | 7 | 2022 | 484 | 0.720 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 2 | 2019 | 67 | 0.620 |
Why?
|
| Depressive Disorder | 1 | 2016 | 218 | 0.510 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2019 | 322 | 0.510 |
Why?
|
| Depression | 3 | 2022 | 473 | 0.500 |
Why?
|
| Hyperthermia, Induced | 1 | 2014 | 73 | 0.480 |
Why?
|
| Depressive Disorder, Major | 3 | 2022 | 158 | 0.480 |
Why?
|
| Shock, Hemorrhagic | 2 | 2011 | 11 | 0.480 |
Why?
|
| Referral and Consultation | 3 | 2021 | 328 | 0.450 |
Why?
|
| Patient Care Team | 1 | 2014 | 280 | 0.420 |
Why?
|
| Myocardium | 2 | 2010 | 529 | 0.380 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 88 | 0.380 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2010 | 8 | 0.370 |
Why?
|
| Cardiac Output | 1 | 2010 | 156 | 0.360 |
Why?
|
| Gene Deletion | 1 | 2010 | 329 | 0.350 |
Why?
|
| Health Personnel | 2 | 2021 | 202 | 0.340 |
Why?
|
| Basal Ganglia | 2 | 1998 | 42 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1036 | 0.300 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 318 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 10 | 2019 | 3092 | 0.300 |
Why?
|
| Community Health Centers | 2 | 2019 | 113 | 0.290 |
Why?
|
| Health Promotion | 2 | 2019 | 160 | 0.280 |
Why?
|
| Middle Aged | 19 | 2023 | 25028 | 0.280 |
Why?
|
| Heart-Assist Devices | 2 | 2023 | 731 | 0.270 |
Why?
|
| Humans | 27 | 2024 | 86643 | 0.260 |
Why?
|
| Blood Glucose | 1 | 2009 | 873 | 0.250 |
Why?
|
| DNA | 1 | 2010 | 1294 | 0.250 |
Why?
|
| Female | 25 | 2023 | 44532 | 0.250 |
Why?
|
| Health Information Exchange | 1 | 2021 | 12 | 0.210 |
Why?
|
| Systems Analysis | 1 | 2021 | 17 | 0.210 |
Why?
|
| Hospitalization | 3 | 2021 | 849 | 0.200 |
Why?
|
| Community Networks | 1 | 2021 | 29 | 0.200 |
Why?
|
| Heart Rate | 1 | 2024 | 492 | 0.200 |
Why?
|
| Occupational Diseases | 1 | 2021 | 55 | 0.190 |
Why?
|
| Respiration | 1 | 2022 | 262 | 0.190 |
Why?
|
| Population Health | 2 | 2019 | 33 | 0.180 |
Why?
|
| Machine Learning | 1 | 2022 | 232 | 0.180 |
Why?
|
| Male | 18 | 2023 | 40965 | 0.180 |
Why?
|
| Hemodynamics | 4 | 2015 | 710 | 0.180 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2705 | 0.180 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2019 | 487 | 0.170 |
Why?
|
| Pandemics | 2 | 2022 | 740 | 0.170 |
Why?
|
| Adult | 13 | 2023 | 25648 | 0.170 |
Why?
|
| Aged | 12 | 2021 | 18415 | 0.170 |
Why?
|
| Electronic Health Records | 2 | 2019 | 319 | 0.170 |
Why?
|
| Mice | 9 | 2015 | 11352 | 0.170 |
Why?
|
| Young Adult | 6 | 2021 | 5976 | 0.160 |
Why?
|
| Hospital Costs | 1 | 2019 | 105 | 0.160 |
Why?
|
| Sensation | 1 | 1998 | 45 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 1565 | 0.160 |
Why?
|
| Emergency Medical Services | 1 | 2010 | 209 | 0.160 |
Why?
|
| Adolescent | 6 | 2021 | 8981 | 0.150 |
Why?
|
| Blood Circulation | 1 | 2017 | 29 | 0.150 |
Why?
|
| Animals | 15 | 2019 | 26582 | 0.150 |
Why?
|
| Heart Massage | 1 | 2017 | 12 | 0.150 |
Why?
|
| Smoking Cessation | 1 | 2019 | 230 | 0.150 |
Why?
|
| Electronic Prescribing | 1 | 2016 | 11 | 0.150 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 139 | 0.150 |
Why?
|
| Disease Progression | 1 | 2021 | 1531 | 0.150 |
Why?
|
| Reperfusion Injury | 2 | 2007 | 131 | 0.140 |
Why?
|
| Retrospective Studies | 6 | 2021 | 8489 | 0.140 |
Why?
|
| Registries | 3 | 2021 | 702 | 0.140 |
Why?
|
| Random Allocation | 5 | 2019 | 332 | 0.130 |
Why?
|
| Primary Health Care | 1 | 2019 | 339 | 0.130 |
Why?
|
| Quinazolinones | 1 | 2015 | 13 | 0.130 |
Why?
|
| Dynamins | 1 | 2015 | 49 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2015 | 2232 | 0.120 |
Why?
|
| Mitochondrial Dynamics | 1 | 2015 | 53 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 128 | 0.120 |
Why?
|
| Organometallic Compounds | 1 | 2015 | 132 | 0.120 |
Why?
|
| Survival Rate | 4 | 2013 | 1863 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 1998 | 584 | 0.120 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 639 | 0.120 |
Why?
|
| Aldehyde-Lyases | 1 | 2013 | 15 | 0.120 |
Why?
|
| Heart Failure | 1 | 2023 | 1204 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2023 | 1805 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 80 | 0.110 |
Why?
|
| Sphingosine | 1 | 2013 | 71 | 0.110 |
Why?
|
| Lysophospholipids | 1 | 2013 | 63 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2015 | 271 | 0.110 |
Why?
|
| Cardiac Catheterization | 2 | 2017 | 291 | 0.110 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2023 | 166 | 0.100 |
Why?
|
| Decision Making | 1 | 2016 | 642 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2011 | 1106 | 0.100 |
Why?
|
| Myoglobin | 1 | 2010 | 29 | 0.090 |
Why?
|
| Sodium Nitrite | 1 | 2009 | 2 | 0.090 |
Why?
|
| Chemokines | 1 | 2010 | 73 | 0.090 |
Why?
|
| Ice | 2 | 2006 | 11 | 0.090 |
Why?
|
| Electron Transport Complex I | 1 | 2009 | 28 | 0.090 |
Why?
|
| Quality of Life | 3 | 2023 | 1585 | 0.090 |
Why?
|
| Ileum | 1 | 2010 | 159 | 0.090 |
Why?
|
| Reactive Oxygen Species | 2 | 2009 | 480 | 0.090 |
Why?
|
| Decision Trees | 2 | 2021 | 63 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 376 | 0.090 |
Why?
|
| Nervous System | 1 | 2009 | 86 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 263 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 782 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2010 | 256 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2009 | 107 | 0.080 |
Why?
|
| Body Temperature | 2 | 2007 | 124 | 0.080 |
Why?
|
| United States | 4 | 2021 | 6672 | 0.080 |
Why?
|
| Anxiety | 2 | 2022 | 287 | 0.080 |
Why?
|
| Hyperglycemia | 1 | 2009 | 176 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 6509 | 0.080 |
Why?
|
| Stroke Volume | 1 | 2010 | 456 | 0.080 |
Why?
|
| Oxidants | 1 | 2007 | 86 | 0.070 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 188 | 0.070 |
Why?
|
| Heart | 1 | 2009 | 539 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 683 | 0.070 |
Why?
|
| Single-Blind Method | 2 | 2021 | 153 | 0.070 |
Why?
|
| Mass Screening | 2 | 2021 | 618 | 0.070 |
Why?
|
| Risk Factors | 2 | 2021 | 5417 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2007 | 275 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2004 | 88 | 0.060 |
Why?
|
| Time Factors | 2 | 2010 | 5210 | 0.060 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 5 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2022 | 839 | 0.060 |
Why?
|
| Mitochondria | 1 | 2007 | 535 | 0.060 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 116 | 0.060 |
Why?
|
| Chicago | 2 | 2019 | 1379 | 0.060 |
Why?
|
| Information Systems | 1 | 2023 | 29 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2015 | 268 | 0.060 |
Why?
|
| Resuscitation | 2 | 2015 | 100 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2011 | 912 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2022 | 4213 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 30 | 0.050 |
Why?
|
| Patient Care | 1 | 2023 | 100 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2021 | 71 | 0.050 |
Why?
|
| Immunization Schedule | 1 | 2021 | 21 | 0.050 |
Why?
|
| Cannula | 1 | 2021 | 47 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 2501 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 806 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 148 | 0.050 |
Why?
|
| Cough | 1 | 2021 | 54 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 112 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2021 | 285 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 429 | 0.050 |
Why?
|
| Kidney | 1 | 2006 | 1241 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2010 | 104 | 0.050 |
Why?
|
| Fever | 1 | 2021 | 125 | 0.050 |
Why?
|
| Swine | 3 | 2006 | 555 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 293 | 0.050 |
Why?
|
| Laparoscopy | 1 | 2006 | 754 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 927 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 426 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 1998 | 17 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2019 | 283 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 138 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2023 | 2379 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2023 | 1981 | 0.040 |
Why?
|
| Poverty | 1 | 2019 | 173 | 0.040 |
Why?
|
| Electrophysiology | 1 | 1998 | 401 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 814 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 1998 | 347 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 1078 | 0.040 |
Why?
|
| Suicidal Ideation | 1 | 2017 | 67 | 0.040 |
Why?
|
| Thalamus | 1 | 1998 | 132 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 1998 | 435 | 0.040 |
Why?
|
| Glucose | 1 | 2019 | 638 | 0.040 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 58 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 454 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2009 | 7993 | 0.040 |
Why?
|
| Medical Informatics | 1 | 2016 | 47 | 0.040 |
Why?
|
| Psychometrics | 1 | 2017 | 327 | 0.030 |
Why?
|
| Synapses | 1 | 1998 | 265 | 0.030 |
Why?
|
| Coronavirus Infections | 1 | 2021 | 301 | 0.030 |
Why?
|
| Suicide | 1 | 2017 | 139 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 702 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1540 | 0.030 |
Why?
|
| Aconitate Hydratase | 1 | 2015 | 11 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1239 | 0.030 |
Why?
|
| Models, Neurological | 1 | 1998 | 405 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 134 | 0.030 |
Why?
|
| Pregnancy | 1 | 2022 | 2894 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2767 | 0.030 |
Why?
|
| Nerve Net | 1 | 1998 | 366 | 0.030 |
Why?
|
| Visual Cortex | 1 | 1997 | 251 | 0.030 |
Why?
|
| Inflammation | 1 | 2019 | 920 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 1143 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 24 | 0.030 |
Why?
|
| Ceramides | 1 | 2013 | 35 | 0.030 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2013 | 36 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1801 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 104 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 103 | 0.030 |
Why?
|
| Imidazoles | 1 | 2013 | 162 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2011 | 27 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 121 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 134 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 268 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 125 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 111 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 307 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 776 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 179 | 0.020 |
Why?
|
| Algorithms | 1 | 1998 | 1830 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 244 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 1924 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 2008 | 65 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 532 | 0.020 |
Why?
|
| Polyenes | 1 | 2007 | 8 | 0.020 |
Why?
|
| Hypocapnia | 1 | 2007 | 6 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2007 | 50 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2007 | 45 | 0.020 |
Why?
|
| Hypercapnia | 1 | 2007 | 43 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2007 | 229 | 0.020 |
Why?
|
| Emergency Medical Technicians | 1 | 2006 | 14 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 268 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 493 | 0.020 |
Why?
|
| Manikins | 1 | 2006 | 41 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2007 | 278 | 0.020 |
Why?
|
| Fatigue | 1 | 2006 | 174 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1683 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 969 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1920 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2006 | 751 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 3241 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2818 | 0.010 |
Why?
|